Join
Live feed
·
PRReleasevia Quantisnow
Entera Bio Ltd. logo
OPKO Health Inc. logo

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTX (Entera Bio Ltd.), OPK (OPKO Health Inc.) and more on Quantisnow.